LITTLE KNOWN FACTS ABOUT BREAST CANCER: BASIC AND CLINICAL RESEARCH.

Specific protein degradation is staying explored as a substitute strategy in cancer, whereby the pure protein degradation program is co-opted for therapeutic needs. Not long ago made novel molecules called proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. One particular ligand binds on t